Skip to main content
RUNBEN BIOTECHNOLOGY CO., LTD. logo

RUNBEN BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603193 ISIN · CNE100006DK5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 269 across all filing types
Latest filing 2024-01-15 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603193

About RUNBEN BIOTECHNOLOGY CO., LTD.

https://www.runben.com/

Runben Biotechnology Co., Ltd. focuses on the research, development, production, and distribution of personal care and household hygiene solutions. The company’s core product portfolio is categorized into mosquito repellents, infant and child care, and essential oil products. Key offerings include electric mosquito repellent liquids, botanical essential oil patches, and specialized skincare items such as moisturizing creams and cleansing products tailored for sensitive skin. Runben prioritizes the integration of biotechnology with natural formulations to ensure product safety and efficacy. By maintaining a strong emphasis on product innovation and quality control, the company serves a broad consumer base through integrated online and offline sales channels, positioning itself as a provider of health-oriented daily necessities for family environments.

Recent filings

Filing Released Lang Actions
第二届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the second meeting of the second board of directors of Runben Biotechnology Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and mentions related announcements for shareholder meetings and related party transactions. There is no financial data, earnings information, or detailed report content. The document focuses on board decisions and governance matters, specifically about lease contracts and calling a shareholders' meeting. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2024-01-15 Chinese
关于召开2024年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a notice about convening the 2024 first extraordinary general meeting of shareholders (临时股东大会) for a company, including details about the meeting date, voting methods, agenda items, and proxy authorization. It does not contain financial statements or results, but rather logistical and procedural information about the shareholder meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document length is 3084 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, the appropriate classification is PSI.
2024-01-15 Chinese
关于签订租赁合同暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the signing of a lease contract and related party transaction involving the company's subsidiaries and its actual controllers. It details the lease terms, related party relationships, pricing policies, and the approval process by the board and independent directors. There is no financial statement or comprehensive financial data presented. The document is a regulatory announcement about a related party transaction and lease agreement, not a financial report or earnings release. It fits best under Regulatory Filings (RNS) as it is a compliance disclosure about a related party transaction and corporate governance matters.
2024-01-15 Chinese
关于全资子公司获得高新技术企业证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the company's wholly-owned subsidiary receiving a High-Tech Enterprise Certificate. It contains no financial statements, no detailed financial data, no management discussion, or regulatory filings. It is a regulatory announcement about a certification received, not a report or detailed filing. The document length is only 582 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-01-10 Chinese
申万宏源证券承销保荐有限责任公司关于润本生物技术股份有限公司2023年度现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2023年度现场检查报告" (2023 Annual On-site Inspection Report) issued by the underwriting and sponsorship institution (申万宏源证券承销保荐有限责任公司) for 润本生物技术股份有限公司. It details the results of an on-site inspection covering governance, internal controls, information disclosure, independence, use of raised funds, related party transactions, and operational status. The document references regulatory requirements from the China Securities Regulatory Commission and Shanghai Stock Exchange self-regulatory guidelines. It is a detailed report of the inspection findings rather than an announcement or a brief summary. The document length is 2963 characters, which is relatively short but contains substantive content and detailed opinions on multiple aspects of the company’s compliance and operations. It is not a full annual report (10-K), nor an audit report (AR), nor a regulatory filing (RNS) or announcement. It is a standalone inspection report by the sponsor, which fits best under the category of Audit Report / Information (AR), as it is a formal audit/inspection report related to regulatory compliance and internal controls, but not a full annual report or financial statement filing. FY 2023
2023-12-29 Chinese
关于润本生物技术股份有限公司2023年第四次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, voting, and resolutions of a 2023 fourth extraordinary shareholders' meeting (临时股东大会) of a company. It details the legality and validity of the meeting's call, attendance, voting methods (including online voting), and the results of various resolutions passed at the meeting, including board elections and amendments to company rules. The document is not a full annual report, audit report, or financial statement, but rather a legal opinion on the shareholders' meeting and its resolutions. It contains detailed voting results and legal compliance statements related to the shareholders' meeting. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholders' meeting.
2023-12-25 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.